A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC

NCT02647125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Huachansu
RADIATION: thoracic radiation

Sponsor

Fudan University